Since IDH1 mutations relate to both astrocytoma and oligodendroglioma, selecting the correct medium is essential to keep the IDH1 mutated model similar to the patient’s condition, because using an inaccurate medium can change the sensitivity of cells to different drugs. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).